Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
PuraPharm Corp. Ltd. ( (HK:1498) ) has issued an announcement.
PuraPharm Corporation Limited has announced a delay in the dispatch of a circular related to the Patent Licence Agreement and Subscription Agreement. Initially scheduled for release by August 15, 2025, the circular will now be dispatched by October 17, 2025, due to the need for additional time to finalize its contents. This postponement may impact the company’s stakeholders as it involves significant agreements and transactions.
More about PuraPharm Corp. Ltd.
PuraPharm Corporation Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. The company focuses on the development and distribution of herbal medicines and related healthcare products.
Average Trading Volume: 195,586
Technical Sentiment Signal: Sell
Current Market Cap: HK$177.7M
Find detailed analytics on 1498 stock on TipRanks’ Stock Analysis page.